v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (17,161) $ (31,154)
Adjustments to reconcile net loss to net cash used in operating activities:    
Noncash interest expense 61 2,496
Gain on extinguishment of debt (1,832)
Loss on extinguishment of debt 7,886
Loss (gain) on change in fair value of convertible notes (2,303) 3,700
Non-cash expenses from settlement of liabilities 1,033
Non-cash issuance of inducement shares in connection with the merger 7,584
Non-cash issuance of warrants associated with ELOC costs 982
Depreciation expense 7
Stock-based compensation expense 501 704
Gain on change in fair value of warrant liabilities (678) (884)
Non-cash warrant issuance expense 2,178
Loss on disposal of digital assets 295
Loss on change in fair value of digital assets 28
Loss on settlement of forward share issuance contract 82
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 445 (118)
Other non-current assets (48) 1
Accounts payable 2,721 3,197
Accrued expenses and other current liabilities (73) 2,345
Net cash used in operating activities (6,886) (11,119)
Cash flows from investing activities    
Sale of digital assets 1,150
Purchases of digital assets (1,000)
Purchases of property, plant and equipment (79)
Net cash provided by (used in) investing activities 1,071 (1,000)
Cash flows from financing activities    
Proceeds from issuance of PIPE notes 2,800 11,000
Proceeds from ELOC 2,858 3,537
Repayment on notes and convertible loans payable (1,281) (1,052)
Proceeds from issuance of convertible senior notes 1,450
Net cash received from the reverse recapitalization 2
Payments for fractional shares in connection with August Reverse Stock Split (1)
Net cash provided by financing activities 4,376 14,937
Net Increase (decrease) in cash (1,439) 2,818
Cash at the beginning of the period 1,778 191
Cash at the end of the period $ 339 $ 3,009
Supplemental disclosures of non-cash investing and financing information:    
Noncash issuance of common stock in connection with conversion of PIPE notes and promissory notes 13,090 46,891
Operating lease right-of-use assets obtained in exchange for operating lease liabilities $ 244
Reversal of excise tax payable attributable to redemption of common stock 1,909
Reclassification of warrant liability to additional paid-in capital 1,798
Noncash issuance of common and Series A non-voting convertible preferred stock in connection with the G3 Call Option 28,327
Noncash issuance of Series A non-voting convertible preferred stock to settle liabilities 3,051
Assumption of net liabilities of Northview 8,399
Issuance of shares in connection with convertible note 7,254
Issuance of shares in connection with ELOC transaction costs 3,537
Issuance of warrants in connection with ELOC costs 982
Issuance of shares in connection with non-recourse note to employees 428
Conversion of preferred stock into common stock 65,149
Issuance of HCW warrants in lieu of cash payment 330
Supplemental disclosure of cash flow information:    
Cash paid for interest 250
Cash paid for taxes $ 13